chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Tuesday night after the shot, no problems. Worked on pick-up wth no aches. Wednesday night at 8pm aftert throwing darts (does not thro darts with left hand) experienced numbness in left arm from shoulder to elbow.  Had problems raising left arm above shoulder level.  Talked with the school nurse on Friday the 29th (he works at the school and received the vaccine at a school based clinic) he started taking Ibuprofen every 6 hrs prn.  It is getting a little better, but still taking Ibuprofen every 8 hrs.
generalized malaise; Headache; injection site soreness; fever beginning 13h post-injection; This spontaneous case was reported by a pharmacist and describes the occurrence of MALAISE (generalized malaise), HEADACHE (Headache), VACCINATION SITE PAIN (injection site soreness) and PYREXIA (fever beginning 13h post-injection) in a 41-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 051D22A) for COVID-19 prophylaxis.    Co-suspect product included non-company product INFLUENZA VACCINE INACT SPLIT 4V (QUADRIVALENT INFLUENZA VACCINE) for an unknown indication.    The patient's past medical history included Viral infection (influenza like viral infection) in October 2022. Previously administered products included for Product used for unknown indication: Pfizer in January 2021 and pfizer in February 2021. Past adverse reactions to the above products included No adverse event with Pfizer and pfizer.   On 20-Nov-2022, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form and dose of INFLUENZA VACCINE INACT SPLIT 4V (QUADRIVALENT INFLUENZA VACCINE) (unknown route) 1 dosage form. In November 2022, the patient experienced MALAISE (generalized malaise), HEADACHE (Headache), VACCINATION SITE PAIN (injection site soreness) and PYREXIA (fever beginning 13h post-injection). At the time of the report, MALAISE (generalized malaise), HEADACHE (Headache), VACCINATION SITE PAIN (injection site soreness) and PYREXIA (fever beginning 13h post-injection) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: (Negative) Home COVID test.     For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not reported.  No known history of Covid-19 Infection.                                        No treatment information was provided by the reporter.   This case was linked to MOD-2022-675780 (Patient Link).
Developed shingles; treated on July 28 with FAMCICLOVIR, 500mg. Ineffective: shingles appeared in their areas of the body. This medication, 1 tab 3x/day for seven days, seemed ineffective. Therefore: On August 10, doctor prescribed VALACYCLOVIR, 1000mg. This medication, 1 tab 3x/day. For 14 days, proved more effective as the irritability/itching subsided, although the shingles scars remain.
pt recv vax; pt afebrile for 48 hr p/ vax;apap adm 1 hr p/ inject;to er;drowsy, high T,crying; painful muscle;T at er 105.6R;motrin & apap advised;no convuls;
Moderna COVID-19 Vaccine EUA. Swollen lymph nodes in my left armpit. Very tender.
Onset of a numbess, tingling, and pain to the right lower leg from the knee to the toes, affecting mainly the calf muscle and front portion of the majority of the lower right leg only.  Symptoms begin mildly on the inner calf muscle and during the night of 10/1 into the AM of 10/2 worsened and spread to the entire right lower leg from knee to toe. Currently somewhat lessened by a 400mg OTC dose of Ibuprofen.
First covid given 12/23/20 side effects were sore arm. Second Covid given 1/20/21, approx. 18 hrs. after shot: chills, fever 100 degrees. Fever through 1/22.
mild headache in the frontal part of her head; Chills occurred overnight; This is a spontaneous report from a contactable female consumer (patient) reported for herself. A 66-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for Injection, Batch/Lot number was not reported), via an unspecified route of administration, administered in arm left (left upper shoulder) on 02Mar2021 09:45 (at the age of 66-year-old) at a 1st dose, single for COVID-19 immunization. Reason for unavailability of lot number was reported as caller did not have product and CDC vaccine record card and paperwork did not have a Lot number recorded on it. Medical history included osteoporosis from 2001 and ongoing (Pertinent Details Include surgical procedures and dates: Around 2001 when she went to endocrinologist she was diagnosed with Osteoporosis), Amoxicillin allergy, codeine allergy, sensitivity to caffeine ongoing, Vitamin D deficiency from 2001 (Pertinent Details Include surgical procedures and dates: Around 2001 she was given a test for menopause, had gone through menopause so she went to an endocrinologist who found her vitamin d level was not enough to support her calcium so she was diagnosed with Vitamin D deficiency and started on medication for that), family medical history relevant to ae(s) was none. The patient concomitant medications were not reported. The patient previously took shingrix for immunisation and experienced tiredness from on an unspecified date in 2019 (Adverse Event: She just had you know the typical symptoms after the injection like tiredness, just kind of blah. Vaccine/Brand Name: Shingles vaccine, she was not sure but thinks it was the Shingrix Vaccine. She though it was the new one, the 2 dose one; she thinks at that time some older people had gotten the old version of the shingles shot but she thinks she and her husband were given the new one, the Shingrix Vaccine: Lot/NDC/Expiry: Unknown, caller did not have product or this information to provide). Patient past drug history included Amoxicillin from on an unspecified date in 2010 and experienced amoxicillin allergy, codeine ongoing and experienced codeine allergy (Pertinent Details Include surgical procedures and dates: Described as just a few of the standard allergies like Amoxicillin allergy; codeine allergy; sensitivity to caffeine. Amoxicillin: Brand name/full product name/Lots/NDCs/Expiries: unknown, does not have product or this information to provide. Codeine: Brand name/full product name/Lots/NDCs/Expiries: Unknown, does not have product or this information to provide). On 02Mar2021 18:00, the patient experienced mild headache in the frontal part of her head, chills occurred overnight. Events had improved by about 12:00 on 03Mar2021. Patient was not hospitalized and did not visit physician office/emergency room for the events. The patient underwent lab tests and procedures which included given a test for menopause diagnosed with vitamin D deficiency on an unspecified date in 2001. Outcome of the events was recovering.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Red flushing over the arms and face (upper). No treatment administered. Duration of event: (1 hr approx.)
the vial was initially stored in the refrigerator on 19-Apr-2021 but administered on 13-Oct-2021; After beyond use date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (After beyond use date) and PRODUCT STORAGE ERROR (the vial was initially stored in the refrigerator on 19-Apr-2021 but administered on 13-Oct-2021) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007C21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 13-Oct-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (After beyond use date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (the vial was initially stored in the refrigerator on 19-Apr-2021 but administered on 13-Oct-2021). At the time of the report, EXPIRED PRODUCT ADMINISTERED (After beyond use date) and PRODUCT STORAGE ERROR (the vial was initially stored in the refrigerator on 19-Apr-2021 but administered on 13-Oct-2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.   Reporter did not allow further contact
C/o tightness of chest,red splotchy rash on neck and chest, spreading to shoulders.  BP 150/82, P 77.  Takes allergy meds,  seen by EMT .and transported to hospital.
GENERAL PAIN; ITCHY BODY; BRUISE IN RIGHT LEG; TIREDNESS; FEVER; CONFIRMED CLINICAL VACCINATION FAILURE; CONFIRMED COVID-19 INFECTION; This spontaneous report received from a patient concerned a female of unspecified age, race and hispanic or latino ethnicity. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805029, expiry: unknown) dose was not reported, 1 total, administered on 20-MAR-2021 on left arm for prophylactic vaccination. No concomitant medications were reported.  On an unspecified date after 10-15 days of vaccination consumer developed tiredness, general pain, itchy body, fever and a bruise in her right leg. Symptoms got better within a month. Then in June 2021 consumer lost taste and smell, had fever and shortness of breath for about 15 days, On an unspecified date in JUN-2021 confirming positive Covid-19 infection by antigen rapid test and PCR (polymerase chain reaction) (confirmed clinical vaccination failure, and confirmed covid-19 infection) done twice during that period of time. Consumer states that Janssen vaccine did not work for her. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from tiredness, general pain, itchy body, bruise in right leg, and fever, and the outcome of confirmed clinical vaccination failure and confirmed covid-19 infection was not reported. This report was serious (Other Medically Important Condition). This report was associated with product quality complaint: 90000216307.; Sender's Comments: V0: 20220215382-COVID-19 VACCINE AD26.COV2.S-Confirmed clinical vaccination failure. This event(s) is considered not related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: SPECIAL SITUATIONS
Low grade fever of 100.5 chills muscle pain other than injection site fatigue  Symptom duration ended approximately 20-24 hours after onset.
23-year-old female sought treatment in the ER with complaints of numbness in the entirety of her left arm after receiving the Hep B shot earlier in the day. Per ER report, she had full strength and reflexes in both upper extremities. She reported decreased sensation throughout left upper extremity, but stated she could feel the Dr. pinch her and has sensation when cap refill tested. There were no signs of infection at the vaccine site. ER stated that it may be a side effect from the Hep B vaccine, but did not see evidence of an emergent problem at that time. She was discharged in stable and improved condition.
Patient recieved vaccinies through CDC in April of 2005 for overseas travel.  Three days after vaccination, patient began having seizures.  Seizures have been spreed out over time; however condition has not been cured.  Patient has seen specialist (nuerologist), administered several medication to treat seizures, participated in clinical trial studies and frequently admitted to Emergency Rooms.
shot rxn caused swelling & redness in a 9 X 7.5 cm portion of upper lt arm, Fever of 102 F X 2 days
Information has been received from a Registered Nurse concerning her daughter an 18 year old female who on an unspecified date was vaccinated with 0.5 ml first dose of GARDASIL (route and lot number not reported). Concomitant therapy included tuberculin purified protein derivative (PPD test). The Nurse stated that "her daughter received the first dose of GARDASIL and the next day she experienced tingling in her fingers (date unspecified). After field hockey practice she started to lose vision and at first it was thought she was dehydrated, she was taken to the emergency room when she experienced shooting pain through the top of her head. Her vision came back and she was released from the emergency room. The patient went to a neurologist who performed an MRI (magnetic resonance imaging) (date not reported) which came back clear and the neurologist diagnosed her with ocular migraines (date unspecified). The patient had not received the second and third dose of GARDASIL. At the time of the report the outcome of the patient was recovered (date unspecified). No further information is available.
Patient reported fever and headache after shot and then swelling and itching that was still present a few days after shot which led to her calling pharmacy. Patient stated she took some Benadryl and it helped and that she was going to follow up with a doctor on Monday (December 7).
This spontaneous case was reported by a nurse and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second given at day 22) in a 29-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011F21A) for COVID-19 vaccination.     No Medical History information was reported.  On 13-Oct-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Oct-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second given at day 22). On 13-Oct-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second given at day 22) had resolved.      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment information was provided.
Pt received wrong type of second vaccine. First vaccine was pfizer. second dose given was Moderna
Stable rectal cancer for 1 year. before vaccination. He could examine himself and needed to insert forefinger all the way to reach the tumor prior to vaccine. It was stable like this for one year. After vaccine tumor immediately had rapid growth. Today on my exam I could feel the tumor inside anal canal.
pimple size nodules; blister sacks with extreme itching on 3 fingers; looks like eczema on both hands; constantly itching and burning; constantly itching and burning; This spontaneous case was reported by a patient and describes the occurrence of ACNE (pimple size nodules), BLISTER (blister sacks with extreme itching on 3 fingers), ECZEMA (looks like eczema on both hands), PRURITUS (constantly itching and burning) and BURNING SENSATION (constantly itching and burning) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032B21A and 007B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-May-2021, the patient experienced ACNE (pimple size nodules), BLISTER (blister sacks with extreme itching on 3 fingers), ECZEMA (looks like eczema on both hands), PRURITUS (constantly itching and burning) and BURNING SENSATION (constantly itching and burning). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency and CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, ACNE (pimple size nodules), BLISTER (blister sacks with extreme itching on 3 fingers), ECZEMA (looks like eczema on both hands), PRURITUS (constantly itching and burning) and BURNING SENSATION (constantly itching and burning) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.   This case was linked to MOD-2021-148313 (Patient Link).
Pt called approx 30 minutes post vaccine complaining of dizziness, headache, nausea and vomiting. Was advised to go to ER where he was given Tylenol for headache and advised it might be a possible reaction to Hep B. 8:30 PM telephone call to pt - states he was improved.
Community Influenza Clinic on 10/22/2019 Patient received her annual influenza immunization at approximately 11:00am without immediate adverse effect.  She returned to the clinic area at approximately 11:25am with complaints of "tingling" sensations in the left side of her mouth and both of her hands.  She told staff, "I really don't feel well at all".  Patient was alert and oriented; she was able to follow all staff directives. No facial drooping, slurred speech, diaphoresis, ataxia or signs of respiratory distress noted.  Patient denied loss of consciousness.She was assisted to a seated position with her head down; an ice pack was applied to the back of her neck; emotional support was given.  Vital Signs, as follows:  * 11:30am:  BP=160/100, AP=134 (1+,reg), R=16 (unlabored)  * 11:35am:  BP=160/100, AP=137 (1+,reg), R=16 (unlabored)    (911/EMS activated at 11;35am, per patient request and because her vital signs were significantly elevated)  * 11:40am:  BP 154/88, AP=128 (1+, reg), R=20 (unlabored)  Patient denied difficulty breathing, throat or mouth edema/swelling or other signs/symptoms of anaphylaxis.    EMS arrived at the scene at 11:45am.  Patient walked independently to the ambulance; no ataxia noted.   They monitored her for an unknown amount of time before patient refused transport. and signed off; it is unknown what occurred in the ambulance to make patient change her mind about going to the hospital.   At approximately 12:45pm; she reported that the left side of her mouth was still "tingling", but that she felt better; she was advised by RN staff to follow-up with her Primary Care Provider.  On 10/23/19, patient was called by Public Health Staff.  Patient reported having the "tingling" sensations until "later in the day" yesterday,  but feels much better today.
On Sunday (04/11) I woke up with pain in my left armpit, this is the arm I got the shot in. It?s still discomfort, but not intense pain and much swelling, but it definitely feels annoying when my arm is down.  My injection site has also been SUPER itchy since day 3, and it?s still warm to touch. I do not have a rash or any redness. I only had redness for about 2 days after the shot
CDC reports: 8 mo infant developed fever to 101.2, wheezing & vomiting for 24 hrs following immunization.
3 weeks of headaches (never get headaches that last more than a day), right leg calf pain still has not stopped. Had a calf sonogram told to get another one in 10 days. I had blood work done 4 weeks prior to First Pfizer shot and again 2 weeks after. MCHC went HIGH, Monocytes went to HIGH, ANION Gap was HIGH, BUN went to HIGH and Glucose went to HIGH. I have been having all these blood test other than ANION Gap every 6 months since 2015 and they have always been in the normal range. Feeling of being dehydrated and new joint pain.
Ache / pain in shoulder area of left arm (where vaccine was administered), especially with any movement. Also painful if pt sleeps on either arm. Pain is alleviated with 325 mg of aspirin in the morning, but pain returns by evening.
Fever Chills Whole Body Soreness Nausea Diarrhea Joint Pain
shoulder pain/when his family member rotates their shoulder, it hurts a little bit; swollenness/ might be swollen; still having injection site pain; maybe the injection didn't go into the muscle of the arm/maybe the injection went into the bursa of the shoulder; shoulder injury; hot in that area; This is a spontaneous report from a contactable consumer or other non-healthcare professional. A 7-decade-old patient of an unspecified gender received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, Batch/Lot number and expiry date: not reported ), via an unspecified route of administration on 01May2021 as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, Batch/Lot number and expiry date: not reported), via an unspecified route of administration on 10Apr2021 (at age of 7 decade) as DOSE 1, SINGLE for covid-19 immunisation. In May2021, the patient still has shoulder pain, some swollenness and it should be hot in that area (was administered almost a week ago). Caller wanted to know if it could be a shoulder vaccination injury and was still having injection site pain and when his family member rotates their shoulder, it hurts a little bit and it might be swollen (May2021). The reporter doesn't believe that this was normal and he can not find any more information about it online and says that maybe the injection did not go into the muscle of the arm and maybe it went into the bursa of the shoulder. The reporter was asking if this has been reported. What are the next steps, does his family member need to see their doctor as doesnot sound normal. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Strange bitter taste in mouth; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the arm left on 02Mar2021 at 11:45 (at the age of 32-year-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history reported as not applicable. The patient did not have known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any concomitant medications. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 02Mar2021, after about 15 minutes (also reported as 11:45), the patient experienced strange bitter taste in mouth and somewhat metallic in nature. It had been another 15 or so minutes and still it was there. The patient did not eat or drink anything hours before and he had still did not drink anything. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event strange bitter taste in mouth was not recovered at the time of report.  No follow-up attempts are needed. No further information is expected.